| | 
Part, Chapter, Paragraph
1 II, 5. 3. 9| Suppl):116-118.~ ~Parkin DM, Bray F, Ferlay J, Pisani
2 II, 5. 5. 3| S28A.~Lehman AF, Steinwachs DM, and Co-investigators of
3 II, 5. 5. 3| 20.~Lehman AF, Steinwachs DM (2003): Evidence-based psychosocial
4 II, 5. 5. 3| Cockerell OC, Eckle I, Goodridge DM, et al (1995): Epilepsy
5 II, 5. 5. 3| Breteler MM, Maraganore DM (1998): Case ascertainment
6 II, 5. 5. 3| Ahlskog JE, Maraganore DM, Muenter MD, Atkinson EJ,
7 II, 5. 6. 6| Lunt M, Purdie D, Reid DM, Rowe R, Woolf AD, Wallace
8 II, 5. 8. 7| Gillespie S, Burney P, Mannino DM, Menezes AMN, Sullivan S,
9 II, 5. 8. 7| 417.~ ~Chapman KR, Mannino DM, Soriano JB, Vermeire PA,
10 II, 5. 8. 7| Badamgarav E, Buist AS, Mannino DM (2006):Global burden of
11 II, 5. 8. 7| 101: 177-185.~ ~Kriegsman DM, Deeg DJ, Stalman WA (2004):
12 II, 5. 8. 7| 29: 223-225.~ ~Mannino DM, Buist AS (2007): Global
13 II, 5. 11. 7| FI, Coebergh JW, Parkin DM (2003): Changing epidemiology
14 II, 5. 11. 7| Bray F, Pisani P, Parkin DM (2001): GLOBOCAN 2000: Cancer
15 II, 5. 14. 8| References~ ~Bourgeois DM, Baehni PC. Surveillance,
16 II, 5. 14. 8| diseases. In: Bourgeois DM, Llodra JC (2004): eds.
17 II, 5. 14. 8| Co. 2004:81–92.~Bourgeois DM (2004): European Global
18 III, 10. 1. 3| Lee W-NP, Burke G, Cooper DM (1998): Fitness and the
19 III, 10. 1. 3| 134.~Marcus BH, Williams DM, Dubbert PM, Sallis JF,
20 III, 10. 2. 1| MB, Williams JM, Ziedonis DM (2006): Developments in
21 III, 10. 2. 1| Holbrook WP, O'Mullane DM (2006): A European perspective
22 III, 10. 2. 1| 32: 69-73.~ ~Bourgeois DM, Baehni PC (2003): Surveillance,
23 III, 10. 2. 1| diseases. In: Bourgeois DM, Llodra JC, eds. Health
24 III, 10. 2. 1| 2004:81–92.~ ~Bourgeois DM, Llodra JC, Pitts N, Norblad
25 III, 10. 2. 1| February 2008)~ ~Bourgeois DM, Llodra JC. Strategies to
26 III, 10. 2. 1| CD002278.~ ~O’Mullane DM, Ketley CE, Cochran JA,Whelton
27 III, 10. 3. 1| Sankila R, Ferlay J, Parkin DM (2002): Estimates of cancer
28 III, 10. 5. 1| Air. (2005) 15:67.~Miller DM, Meek F, (2004): Cost and
29 III, 10. 6. 1| 1.6. References~ ~Austin DM, et al (2002): The effects
30 IV, 11. 6. 5| Economics 12: 431-57.~ ~Cutler DM (2002): "Equality, efficiency,
31 IV, 12. 2 | of previously undiagnosed DM and IGT in patients with
|
|
| |
